ResMed (RMD) Revenue — Quarter Ended Mar 31, 2023
Revenue increased in the current quarter. The growth rate compared to the same quarter last year was notably higher than the sequential change from the prior quarter.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q3
Revenue increased in the current quarter. The growth rate compared to the same quarter last year was notably higher than the sequential change from the prior quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
+8.0%
Change from the immediately preceding quarter.
Year-over-year
+29.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $914.7M | +4.4% |
| Sep 30, 2022 | $950.3M | +5.1% |
| Dec 31, 2022 | $1B | +15.5% |
| Mar 31, 2023 | $1.1B | +29.2% |
Revenue performance
Reported revenue rose from the immediately preceding quarter. The year-over-year comparison also showed an increase, with the annual growth rate exceeding the sequential rate.
Quarterly comparison
Compared to the prior quarter, revenue improved. Relative to the same quarter one year earlier, revenue was also higher, and the year-over-year change was larger than the quarter-over-quarter change.
What to watch
The filing context mentions supply chain disruptions as a factor that may affect future cash from operations.